Congratulations to our members on receiving CIHR project funding
3 August 2022
Click on the links below to learn more about each of their projects:
- Troy Baldwin's project title:
Ontogeny of T cell control by BTLA and PD-1. - Xavier Clemente-Casares's project title:
The role of CSF2RB1 ligands in cancer-associated cachexia. - Carlos Velázquez-Martínez's project title:
FOXM1 protein-targeted degradation and its potential role in the treatment of ovarian cancer: a medicinal chemistry approach. - Michael Woodside's and Tom Hobman's project title:
Probing the role of mechanical rigidity in viral xrRNAs as the key to preventing their degradation by host RNases.
Visit the CIHR website for more information on their Spring 2022 competition.